WHO Calls for Emergency Use Listing of Mpox Tests
WHO invited manufacturers of mpox IVDs to submit expressions of interest for Emergency Use Listing in response to rising cases in Africa.
Read MorePosted by Andy Lundin | Aug 30, 2024 | Sexually Transmitted Diseases |
WHO invited manufacturers of mpox IVDs to submit expressions of interest for Emergency Use Listing in response to rising cases in Africa.
Read MorePosted by Andy Lundin | Aug 29, 2024 | Sexually Transmitted Diseases |
QuidelOrtho received FDA 510(k) clearance for its VITROS syphilis assay, expanding its test portfolio to address the syphilis epidemic.
Read MorePosted by Chris Wolski | Aug 29, 2024 | Sexually Transmitted Diseases |
Eurofins has launched the Mplex Mpox, Orthopox real-time PCR assay for the qualitative detection and differentiation of the mpox virus.
Read MorePosted by Andy Lundin | Aug 28, 2024 | Sexually Transmitted Diseases |
Virax Biolabs secured a distribution agreement to commercialize Mpox detection kits across Europe and for Gulf Cooperation Council nations.
Read MorePosted by Chris Wolski | Aug 26, 2024 | Company News |
Quest Diagnostics has completed its acquisition of LifeLabs from OMERS for approximately CAN $1.35 billion.
Read More